VEGF 165 (N-Term) Antikörper
-
- Target
- VEGF 165
-
Bindungsspezifität
- N-Term
- Reaktivität
- Human, Maus, Ratte, Zebrafisch (Danio rerio)
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (IHC), ELISA
- Spezifität
- Reacts with VEGF165 from human, mouse, rat, Zebrafish and other species
- Aufreinigung
- Purified (protein A)
- Immunogen
- Synthetic peptide derived from N terminal part of human VEGF165.
-
-
- Applikationshinweise
-
Working dilution: Optimal dilutions should be determined by the end user.
The following are guidelines only:
WB1/500 to 1/5 000 IHC1/200 to 1/2000 - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Must be reconstituted in distilled water.
- Konzentration
- 1 mg/mL
- Buffer
- Tris 0,1M, glycine 0,1M, sucrose 2 %
- Lagerung
- 4 °C/-20 °C
- Informationen zur Lagerung
- Lyophilized powder stable for a minimum of 2 years at -20°C. Store reconstituted antibodies at +4°C. For extended periods store in aliquots at -20°C. Antibodies are guaranteed for 6 month from date of receipt.
- Haltbarkeit
- 24 months
-
- Target
- VEGF 165
- Andere Bezeichnung
- VEGF165
- Hintergrund
- Growth factor active in angiogenesis, vasculogenesis and endothelial cell growth. Induces endothelial cell proliferation, promotes cell migration, inhibits apoptosis and induces permeabilization of blood vessels. Binds to the FLT1/VEGFR1 and KDR/VEGFR2 receptors, heparan sulfate and heparin. NRP1/Neuropilin-1 binds isoforms VEGF-165 and VEGF-145.
- Gen-ID
- 7422
- UniProt
- P15692
-